Praxis Precision Medicines, Inc. (PRAX)
318.36
+5.76
(+1.84%)
USD |
NASDAQ |
Jan 22, 10:47
Praxis Precision Medicines Shareholders Equity (Quarterly): 343.50M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 18.39M |
| Aldeyra Therapeutics, Inc. | 49.24M |
| Viridian Therapeutics, Inc. | 502.97M |
| Arrowhead Pharmaceuticals, Inc. | 466.05M |
| BioMarin Pharmaceutical, Inc. | 6.057B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 396.39M |
| Total Liabilities (Quarterly) | 52.88M |
| Debt to Equity Ratio | 0.0013 |
| Current Ratio | 5.178 |
| Net Debt Paydown Yield | 0.03% |